1. SouthCD, HampelH, ComerasI, et al.The frequency of Muir‐Torre syndrome among Lynch syndrome families. J Natl Cancer Inst2008;100:277. CrossRef

2. EisenDB, MichaelDJ. Sebaceous lesions and their associated syndromes: part II. J Am Acad Dermatol2009;61:563. CrossRef

3. PontiG, Ponz de LeonM. Muir‐Torre syndrome. Lancet Oncol2005;6:980. CrossRef

4. LeeBA, YuL, MaL, et al.Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co‐existing visceral tumors. J Am Acad Dermatol2012;67:1228. CrossRef

5. VasenHF, WatsonP, MecklinJP, et al.New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology1999;116:1453. CrossRef

6. PinolV, CastellsA, AndreuM, et al.Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA2005;293:1986. CrossRef

7. GardnerEJ, RichardsRC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet1953;5:139.

8. GaliatsatosP, FoulkesWD. Familial adenomatous polyposis. Am J Gastroenterol2006;101:385. CrossRef

9. JuhnE, KhachemouneA. Gardner syndrome: skin manifestations, differential diagnosis and management. Am J Clin Dermatol2010;11:117. CrossRef

10. CooperPH, FechnerRE. Pilomatricoma‐like changes in the epidermal cysts of Gardner's syndrome. J Am Acad Dermatol1983;8:639. CrossRef

11. ShahKR, BolandCR, PatelM, et al.Cutaneous manifestations of gastrointestinal disease: part I. J Am Acad Dermatol2013;68:189 e1. CrossRef

12. BubienV, BonnetF, BrousteV, et al.High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet2013;50:255. CrossRef

13. SalemOS, SteckWD. Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol1983;8:686. CrossRef

14. RapiniRP, GolitzLE. Sclerotic fibromas of the skin. J Am Acad Dermatol1989;20:266. CrossRef

15. BeggsAD, LatchfordAR, VasenHF, et al.Peutz‐Jeghers syndrome: a systematic review and recommendations for management. Gut2010;59:975. CrossRef

16. DormandyTL. The Peutz‐Jeghers syndrome. Proc R Soc Med1958;51:426.

17. LiQ, JiangQ, PfendnerE, et al.Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Dermatol2009;18:1. CrossRef

18. ChassaingN, MartinL, CalvasP, et al.Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet2005;42:881. CrossRef

19. FruhwirthH, RablH, HauserH, et al.Endoscopic findings in pseudoxanthoma elasticum. Endoscopy1994;26:507. CrossRef

20. LebwohlM, LebwohlE, BercovitchL. Prominent mental (chin) crease: a new sign of pseudoxanthoma elasticum. J Am Acad Dermatol2003;48:620. CrossRef

21. Bayrak‐ToydemirP, McDonaldJ, MarkewitzB, et al.Genotype‐phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A2006;140:463. CrossRef

22. GallioneC, AylsworthAS, BeisJ, et al.Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP‐HHT syndrome. Am J Med Genet A2010;152A:333. CrossRef

23. GallioneCJ, RepettoGM, LegiusE, et al.A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet2004;363:852. CrossRef

24. O'MalleyM, LaGuardiaL, KaladyMF, et al.The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum2012;55:886. CrossRef

25. VaseP, GroveO. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology1986;91:1079.

26. SchwenterF, FaughnanME, GradingerAB, et al.Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation. J Gastroenterol2012;47:795. CrossRef

27. WeiAH, LiW. Hermansky‐Pudlak syndrome: pigmentary and non‐pigmentary defects and their pathogenesis. Pigment Cell Melanoma Res2013;26:176. CrossRef

28. Carmona‐RiveraC, GolasG, HessRA, et al.Clinical, molecular, and cellular features of non‐Puerto Rican Hermansky‐Pudlak syndrome patients of Hispanic descent. J Invest Dermatol2011;131:2394. CrossRef

29. HazzanD, SewardS, StockH, et al.Crohn's‐like colitis, enterocolitis and perianal disease in Hermansky‐Pudlak syndrome. Colorectal Dis2006;8:539. CrossRef

30. BoydKP, KorfBR, TheosA. Neurofibromatosis type 1. J Am Acad Dermatol2009;61:1. CrossRef

31. BasileU, CavallaroG, PolistenaA, et al.Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis. J Gastrointest Surg2010;14:186. CrossRef

32. AgaimyA, VassosN, CronerRS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol2012;5:852.

33. WoutersV, LimayeN, UebelhoerM, et al.Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper‐phosphorylating effects. Eur J Hum Genet2010;18:414. CrossRef

34. OksuzogluBC, OksuzogluG, CakirU, et al.Blue rubber bleb nevus syndrome. Am J Gastroenterol1996;91:780.

35. WongCH, TanYM, ChowWC, et al.Blue rubber bleb nevus syndrome: a clinical spectrum with correlation between cutaneous and gastrointestinal manifestations. J Gastroenterol Hepatol2003;18:1000. CrossRef

36. FishmanSJ, SmithersCJ, FolkmanJ, et al.Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg2005;241:523. CrossRef

37. PepinM, SchwarzeU, Superti‐FurgaA, et al.Clinical and genetic features of Ehlers‐Danlos syndrome type IV, the vascular type. N Engl J Med2000;342:673. CrossRef

38. GermainDP, Herrera‐GuzmanY. Vascular Ehlers‐Danlos syndrome. Ann Genet2004;47:1. CrossRef

39. SolomonJA, AbramsL, LichtensteinGR. GI manifestations of Ehlers‐Danlos syndrome. Am J Gastroenterol1996;91:2282.

40. GeiserJ, VenkenKJ, De LisleRC, et al.A mouse model of acrodermatitis enteropathica: loss of intestine zinc transporter ZIP4 (Slc39a4) disrupts the stem cell niche and intestine integrity. PLoS Genet2012;8:e1002766. CrossRef

41. MaverakisE, FungMA, LynchPJ, et al.Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol2007;56:116. CrossRef

42. SweetserS, BoardmanLA. Cronkhite‐Canada syndrome: an acquired condition of gastrointestinal polyposis and dermatologic abnormalities. Gastroenterol Hepatol (N Y)2012;8:201.

43. SweetserS, AhlquistDA, OsbornNK, et al.Clinicopathologic features and treatment outcomes in Cronkhite‐Canada syndrome: support for autoimmunity. Dig Dis Sci2012;57:496. CrossRef

44. FregoneseL, StolkJ. Hereditary alpha‐1‐antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis2008;3:16. CrossRef

45. ValverdeR, RosalesB, Ortiz‐de FrutosFJ, et al.Alpha‐1‐antitrypsin deficiency panniculitis. Dermatol Clin2008;26:447. CrossRef

46. CallewaertB, SuCT, Van DammeT, et al.Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. Hum Mutat2013;34:111. CrossRef

47. BerkDR, BentleyDD, BaylissSJ, et al.Cutis laxa: a review. J Am Acad Dermatol2012;66:842 e1.

48. BologniaJL, BrewerYP, CooperDL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore)1991;70:269. CrossRef

49. TorleyD, BellusGA, MunroCS. Genes, growth factors and acanthosis nigricans. Br J Dermatol2002;147:1096. CrossRef

50. SchwartzRA. Acanthosis nigricans. J Am Acad Dermatol1994;31:1. CrossRef

51. SchwartzRA. Sign of Leser‐Trelat. J Am Acad Dermatol1996;35:88. CrossRef

52. GrobJJ, RavaMC, GouvernetJ, et al.The relation between seborrheic keratoses and malignant solid tumours. A case‐control study. Acta Derm Venereol1991;71:166.

53. Remes‐TrocheJM, Garcia‐de‐AcevedoB, Zuniga‐VargaJ, et al.Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome. J Eur Acad Dermatol Venereol2004;18:591. CrossRef

54. TierneyEP, BadgerJ. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature. MedGenMed2004;6:4.

55. NovacekG. Plummer‐Vinson syndrome. Orphanet J Rare Dis2006;1:36. CrossRef

56. BellHK, PostonGJ, VoraJ, et al.Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol2005;152:71. CrossRef

57. MarounJ, KochaW, KvolsL, et al.Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Curr Oncol2006;13:67.

58. ObergKE. Gastrointestinal neuroendocrine tumors. Ann Oncol2010;21(Suppl 7):vii72. CrossRef

59. SleePH, van der WaalRI, Schagen van LeeuwenJH, et al.Paraneoplastic hypertrichosis lanuginosa acquisita: uncommon or overlooked?Br J Dermatol2007;157:1087. CrossRef

60. MailleferRH, GreydanusMP. To B or not to B: is tylosis B truly benign? Two North American genealogies. Am J Gastroenterol1999;94:829.

61. BlaydonDC, EtheridgeSL, RiskJM, et al.RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet2012;90:340. CrossRef

62. SmartH, KiaR, SubramanianS, et al.Defining the endoscopic appearances of tylosis using conventional and narrow‐band imaging: a case series. Endoscopy2011;43:727. CrossRef

63. ChandaJJ. Extramammary Paget's disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol1985;13:1009. CrossRef

64. ParkS, GrossfeldGD, McAninchJW, et al.Extramammary Paget's disease of the penis and scrotum: excision, reconstruction and evaluation of occult malignancy. J Urol2001;166:2112. CrossRef

65. SpencerPS, HelmTN. Skin metastases in cancer patients. Cutis1987;39:119.

66. HuSC, ChenGS, WuCS, et al.Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. J Am Acad Dermatol2009;60:379. CrossRef

67. SaeedS, KeehnCA, MorganMB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol2004;31:419. CrossRef

68. CrohnBB, GinzburgL, OppenheimerGD. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer. JAMA1984;251:73. CrossRef

69. BurgdorfW. Cutaneous manifestations of Crohn's disease. J Am Acad Dermatol1981;5:689. CrossRef

70. RankinGB, WattsHD, MelnykCS, et al.National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology1979;77:914.

71. LatianoA, PalmieriO, ValvanoRM, et al.Contribution of IBD5 locus to clinical features of IBD patients. Am J Gastroenterol2006;101:318. CrossRef

72. SiroyA, WasmanJ. Metastatic Crohn disease: a rare cutaneous entity. Arch Pathol Lab Med2012;136:329. CrossRef

73. VaidRM, CohenBA. Cutaneous Crohn's disease in the pediatric population. Pediatr Dermatol2010;27:279. CrossRef

74. PalamarasI, El‐JabbourJ, PietropaoloN, et al.Metastatic Crohn's disease: a review. J Eur Acad Dermatol Venereol2008;22:1033. CrossRef

75. RuoccoE, SangiulianoS, GravinaAG, et al.Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol2009;23:1008. CrossRef

76. BinusAM, QureshiAA, LiVW, et al.Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol2011;165:1244. CrossRef

77. FarhiD, CosnesJ, ZiziN, et al.Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore)2008;87:281. CrossRef

78. HadiA, LebwohlM. Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol2011;64:950. CrossRef

79. BernsteinCN, BlanchardJF, RawsthorneP, et al.The prevalence of extraintestinal diseases in inflammatory bowel disease: a population‐based study. Am J Gastroenterol2001;96:1116. CrossRef

80. LanganSM, GrovesRW, CardTR, et al.Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol2012;132:2166. CrossRef

81. MillerJ, YentzerBA, ClarkA, et al.Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol2010;62:646. CrossRef

82. StorwickGS, PrihodaMB, FultonRJ, et al.Pyodermatitis‐pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol1994;31:336. CrossRef

83. HegartyAM, BarrettAW, ScullyC. Pyostomatitis vegetans. Clin Exp Dermatol2004;29:1. CrossRef

84. KethuSR. Extraintestinal manifestations of inflammatory bowel diseases. J Clin Gastroenterol2006;40:467. CrossRef

85. LarsenS, BendtzenK, NielsenOH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med2010;42:97. CrossRef

86. YukselI, BasarO, AtasevenH, et al.Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis2009;15:546. CrossRef

87. GreensteinAJ, JanowitzHD, SacharDB. The extra‐intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore)1976;55:401. CrossRef

88. ChavanM, JainH, DiwanN, et al.Recurrent aphthous stomatitis: a review. J Oral Pathol Med2012;41:577. CrossRef

89. VavrickaSR, BrunL, BallabeniP, et al.Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol2011;106:110. CrossRef

90. MorganAJ, SchwartzRA. Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol2010;49:750. CrossRef

91. DaoudMS, HuttonKP, GibsonLE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol1997;136:706. CrossRef

92. IshiguroN, KawashimaM. Cutaneous polyarteritis nodosa: a report of 16 cases with clinical and histopathological analysis and a review of the published work. J Dermatol2010;37:85. CrossRef

93. MinkowitzG, SmollerBR, McNuttNS. Benign cutaneous polyarteritis nodosa. Relationship to systemic polyarteritis nodosa and to hepatitis B infection. Arch Dermatol1991;127:1520. CrossRef

94. KemmettD, HunterJA. Sweet's syndrome: a clinicopathologic review of twenty‐nine cases. J Am Acad Dermatol1990;23:503. CrossRef

95. AliM, DuerksenDR. Ulcerative colitis and Sweet's syndrome: a case report and review of the literature. Can J Gastroenterol2008;22:296.

96. CohenPR. Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis2007;2:34. CrossRef

97. BolotinD, Petronic‐RosicV. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol2011;64:1017. CrossRef

98. SardyM, KarpatiS, MerklB, et al.Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med2002;195:747. CrossRef

99. MolbergO, McAdamSN, KornerR, et al.Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut‐derived T cells in celiac disease. Nat Med1998;4:713. CrossRef

100. BolotinD, Petronic‐RosicV. Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol2011;64:1027. CrossRef

101. KouroshAS, YanceyKB. Pathogenesis of mucous membrane pemphigoid. Dermatol Clin2011;29:479. CrossRef

102. NaylorMF, MacCartyRL, RogersRS3rd.Barium studies in esophageal cicatricial pemphigoid. Abdom Imaging1995;20:97. CrossRef

103. GuptaR, WoodleyDT, ChenM. Epidermolysis bullosa acquisita. Clin Dermatol2012;30:60. CrossRef

104. ZumelzuC, Le Roux‐VilletC, LoiseauP, et al.Black patients of African descent and HLA‐DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J Invest Dermatol2011;131:2386. CrossRef

105. ChenM, O'TooleEA, SanghaviJ, et al.The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol2002;118:1059. CrossRef

106. ReddyH, ShipmanAR, WojnarowskaF. Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature. Clin Exp Dermatol2013;38:225. CrossRef

107. LukeMC, DarlingTN, HsuR, et al.Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol1999;135:954.

108. BystrynJC, RudolphJL. Pemphigus. Lancet2005;366:61. CrossRef

109. SuO, OnsunN, Meric TekerA, et al.Upper airway tract and upper gastrointestinal tract involvement in patients with pemphigus vulgaris. Eur J Dermatol2010;20:792.

110. GalloroG, MignognaM, de WerraC, et al.The role of upper endoscopy in identifying oesophageal involvement in patients with oral pemphigus vulgaris. Dig Liver Dis2005;37:195. CrossRef

111. BlancoR, Martinez‐TaboadaVM, Rodriguez‐ValverdeV, et al.Henoch‐Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum1997;40:859. CrossRef

112. ByunJW, SongHJ, KimL, et al.Predictive factors of relapse in adult with Henoch‐Schonlein purpura. Am J Dermatopathol2012;34:139. CrossRef

113. ThrashB, PatelM, ShahKR, et al.Cutaneous manifestations of gastrointestinal disease: part II. J Am Acad Dermatol2013;68:211 e1. CrossRef

114. SapsM, DhrooveG, ChogleA. Henoch‐Schonlein purpura leads to functional gastrointestinal disorders. Dig Dis Sci2011;56:1789. CrossRef

115. JorizzoJL, ApisarnthanaraxP, SubrtP, et al.Bowel‐bypass syndrome without bowel bypass. Bowel‐associated dermatosis‐arthritis syndrome. Arch Intern Med1983;143:457. CrossRef

116. SteinHB, SchlappnerOL, BoykoW, et al.The intestinal bypass: arthritis‐dermatitis syndrome. Arthritis Rheum1981;24:684. CrossRef

117. TruchueloMT, AlcantaraJ, Vano‐GalvanS, et al.Bowel‐associated dermatosis‐arthritis syndrome: another cutaneous manifestation of inflammatory intestinal disease. Int J Dermatol2013;52:1596. CrossRef

118. ScheinfeldN. Malignant atrophic papulosis. Clin Exp Dermatol2007;32:483. CrossRef

119. TheodoridisA, MakrantonakiE, ZouboulisCC. Malignant atrophic papulosis (Kohlmeier‐Degos disease) – a review. Orphanet J Rare Dis2013;8:10. CrossRef

120. KatzSK, MuddLJ, RoenigkHHJr. Malignant atrophic papulosis (Degos' disease) involving three generations of a family. J Am Acad Dermatol1997;37:480. CrossRef

121. MagroCM, PoeJC, KimC, et al.Degos disease: a C5b‐9/interferon‐alpha‐mediated endotheliopathy syndrome. Am J Clin Pathol2011;135:599. CrossRef

122. HighWA, ArandaJ, PatelSB, et al.Is Degos' disease a clinical and histological end point rather than a specific disease?J Am Acad Dermatol2004;50:895. CrossRef

123. KimDW, KangSB, LeeKH, et al.Degos' disease (malignant atrophic papulosis) as a fatal cause of acute abdomen: report of a case. Surg Today2008;38:866. CrossRef

124. PigaM, MathieuA. Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region. Rheumatology (Oxford)2011;50:299. CrossRef

125. SaadounD, WechslerB. Behcet's disease. Orphanet J Rare Dis2012;7:20. CrossRef

126. Anon. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet1990;335:1078.

127. DavatchiF, Assaad‐KhalilS, CalamiaKT, et al.The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol2014;28:338. CrossRef

128. OhSH, HanEC, LeeJH, et al.Comparison of the clinical features of recurrent aphthous stomatitis and Behcet's disease. Clin Exp Dermatol2009;34:e208. CrossRef

129. YurdakulS, TuzunerN, YurdakulI, et al.Gastrointestinal involvement in Behcet's syndrome: a controlled study. Ann Rheum Dis1996;55:208. CrossRef

130. SerraoR, ZirwasM, EnglishJC. Palmar erythema. Am J Clin Dermatol2007;8:347. CrossRef

131. NiederauC, LangeS, FruhaufM, et al.Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis. Liver Int2008;28:659. CrossRef

132. KhasnisA, GokulaRM. Spider nevus. J Postgrad Med2002;48:307.

133. LiCP, LeeFY, HwangSJ, et al.Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol2003;9:2832. CrossRef

134. TerryR. White nails in hepatic cirrhosis. Lancet1954;266:757. CrossRef

135. JemecGB, KollerupG, JensenLB, et al.Nail abnormalities in nondermatologic patients: prevalence and possible role as diagnostic aids. J Am Acad Dermatol1995;32:977. CrossRef

136. SatapathySK, BernsteinD. Dermatologic disorders and the liver. Clin Liver Dis2011;15:165. CrossRef

137. RisheE, AzarmA, BergasaNV. Itch in primary biliary cirrhosis: a patients' perspective. Acta Derm Venereol2008;88:34. CrossRef

138. BunchorntavakulC, ReddyKR. Pruritus in chronic cholestatic liver disease. Clin Liver Dis2012;16:331. CrossRef

139. ImamMH, GossardAA, SinakosE, et al.Pathogenesis and management of pruritus in cholestatic liver disease. J Gastroenterol Hepatol2012;27:1150. CrossRef

140. KremerAE, van DijkR, LeckieP, et al.Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology2012;56:1391. CrossRef

141. Ryan CaballesF, SendiH, BonkovskyHL. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int2012;32:880. CrossRef

142. ChuangTY, BrashearR, LewisC. Porphyria cutanea tarda and hepatitis C virus: a case‐control study and meta‐analysis of the literature. J Am Acad Dermatol1999;41:31. CrossRef

143. HerreroC, VicenteA, BrugueraM, et al.Is hepatitis C virus infection a trigger of porphyria cutanea tarda?Lancet1993;341:788. CrossRef

144. BonkovskyHL, Poh‐FitzpatrickM, PimstoneN, et al.Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology1998;27:1661. CrossRef

145. SontheimerRD. Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. J Invest Dermatol2009;129:1088. CrossRef

146. ShengyuanL, SongpoY, WenW, et al.Hepatitis C virus and lichen planus: a reciprocal association determined by a meta‐analysis. Arch Dermatol2009;145:1040. CrossRef

147. el DaroutiM, Abu el ElaM. Necrolytic acral erythema: a cutaneous marker of viral hepatitis C. Int J Dermatol1996;35:252. CrossRef

148. RaphaelBA, Dorey‐SteinZL, LottJ, et al.Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection. J Am Acad Dermatol2012;67:962. CrossRef

149. El‐DaroutiMA, MashalyHM, El‐NabarawyE, et al.Leukocytoclastic vasculitis and necrolytic acral erythema in patients with hepatitis C infection: do viral load and viral genotype play a role?J Am Acad Dermatol2010;63:259. CrossRef

150. AbdallahMA, GhozziMY, MonibHA, et al.Necrolytic acral erythema: a cutaneous sign of hepatitis C virus infection. J Am Acad Dermatol2005;53:247. CrossRef

151. CacoubP, PoynardT, GhillaniP, et al.Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum1999;42:2204. CrossRef

152. DupinN, ChosidowO, LunelF, et al.Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol1995;131:1124. CrossRef

153. CacoubP, SaadounD. Hepatitis C virus infection induced vasculitis. Clin Rev Allergy Immunol2008;35:30. CrossRef

154. DammaccoF, LaulettaG, MontroneM, et al.Mixed cryoglobulinemia: a model of virus‐related disease in internal medicine. Dig Liver Dis2007;39(Suppl 1):S8. CrossRef

155. BrandtO, AbeckD, GianottiR, et al.Gianotti‐Crosti syndrome. J Am Acad Dermatol2006;54:136. CrossRef

156. PoppJWJr, HarristTJ, DienstagJL, et al.Cutaneous vasculitis associated with acute and chronic hepatitis. Arch Intern Med1981;141:623. CrossRef

157. GowerRG, SauskerWF, KohlerPF, et al.Small vessel vasculitis caused by hepatitis B virus immune complexes. Small vessel vasculitis and HBsAG. J Allergy Clin Immunol1978;62:222. CrossRef

158. Garcia‐RomeroD, VanaclochaF. Pancreatic panniculitis. Dermatol Clin2008;26:465. CrossRef

159. RequenaL, Sanchez YusE. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol2001;45:325. CrossRef

160. LankischPG, Weber‐DanyB, MaisonneuveP, et al.Skin signs in acute pancreatitis: frequency and implications for prognosis. J Intern Med2009;265:299. CrossRef

161. CacoubP, BourliereM, LubbeJ, et al.Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct‐acting antivirals. J Hepatol2012;56:455. CrossRef

162. BrokJ, GluudLL, GluudC. Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database Syst Rev2010;(1):CD005445.

163. RoujeauJC, MockenhauptM, TahanSR, et al.Telaprevir‐related dermatitis. JAMA Dermatol2013;149:152. CrossRef

164. LopezV, MolinaI, MonteagudoC, et al.Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature. Int J Dermatol2011;50:287. CrossRef

165. DoyleMK, BerggrenR, MagnusJH. Interferon‐induced sarcoidosis. J Clin Rheumatol2006;12:241. CrossRef

166. IorizzoM, JorizzoJL. Skin lesions associated with gastrointestinal and liver diseases. In: YamadaT(ed). Textbook of Gastroenterology, 5th ed. Hoboken: Wiley Blackwell; 2008; 2755. CrossRef